Icon

VERAPAMIL HYDROCHLORIDE (nda018925)- (5MG/2ML (2.5MG/ML),10MG/4ML (2.5MG/ML))

VERAPAMIL HYDROCHLORIDE EXELA PHARMA
5MG/2ML (2.5MG/ML),10MG/4ML (2.5MG/ML)
No No
Expired Expired
None None
None No
Verapamil is indicated for the treatment of supraventricular tachyarrhythmias, including: • Rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to Verapamil administration. • Temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation, except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes).
7 0 5
Total Other Developers 48
Drugs with Suitability No
5MG/2ML (2.5MG/ML) ** ** - - -
10MG/4ML (2.5MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* *******, ***. *********** ******* *** *****, ***** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ******* ****** ********** ***** ******* ******* *********** **** **. ***, ***, ***, ***, *** (****) *** *** (****), ********** ***** ****** **** (***), ******** (******), *************, ****** ******* ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** **. **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ** ******, ***** (***) ***
****** ******** ******* *** ******** ************ ******* ******* *********** **/*, ******** ******* *********** *****, *********, ********* ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** ***-***, ** *****, ****** **** ****, *****, *********** ********** ****, *********, ********* ******, ***** (***) ***
****** ****** ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.